Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1915-1917

  Bellmann Weiler, Rosa ^a   Ausserwinkler, Mathias ^a   Kurz, Katharina ^a   Theurl, Igor ^a   Weiss, Guenter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; PROCALCITONIN; SODIUM;

ADULT; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FERRITINS; HOSPITALIZATION; HUMANS; LEGIONNAIRES' DISEASE; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM;

LEGIONELLA; LEGIONELLA PNEUMOPHILA; STREPTOCOCCUS PNEUMONIAE;

EID: 77951794823     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01348-09     Document Type: Article

References (20)

1. Bartlett, J. G. 2008. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin. Infect. Dis. 47(Suppl. 3):S232-S236.
2. Christ-Crain, M., D. Stolz, R. Bingisser, C. Mueller, D. Miedinger, P. R. Huber, W. Zimmerli, S. Harbarth, M. Tamm, and B. Mueller. 2006. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 174:84-93.
3. Cianciotto, N. P. 2007. Iron acquisition by Legionella pneumophila. Biometals 20:323-331.
4. del Mar García-Suárez, M., M. D. Cima-Cabal, R. Villaverde, E. Espinosa, M. Falguera, J. R. de los Toyos, F. Vázquez, and F. J. Méndez. 2007. Performance of a pneumolysin enzyme-linked immunosorbent assay for diagnosis of pneumococcal infections. J. Clin. Microbiol. 45:3549-3554.
5. Diederen, B. M. 2008. Legionella spp. and Legionnaires' disease. J. Infect. 56:1-12.
6. el-Ebiary, M., X. Sarmiento, A. Torres, S. Nogué, E. Mesalles, M. Bodí, and J. Almirall. 1997. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am. J. Respir. Crit. Care Med. 156:1467-1472.
7. Flanders, S. A., J. Stein, G. Shochat, K. Selers, M. Holland, J. Maselli, W. L. Drew, A. L. Reingold, and R. Gonzales. 2004. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am. J. Med. 116:529-535.
8. Gaïni, S., O. G. Koldkjaer, C. Pedersen, and S. S. Pedersen. 2006. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit. Care 10:R53. (Pubitemid 47079872)
9. Haeuptle, J., R. Zaborsky, R. Fiumefreddo, A. Trampuz, I. Steffen, R. Frei, M. Christ-Crain, B. Mueller, and P. Schuetz. 2009. Prognostic value of procalcitonin in Legionella pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 28:55-60.
10. Helbig, J. H., S. A. Uldum, S. Bernander, P. C. Lück, G. Wewalka, B. Abraham, V. Gaia, and T. G. Harrison. 2003. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial Legionnaires' disease. J. Clin. Microbiol. 41:838-840.
11. Houck, P. M., D. W. Bratzler, W. Nsa, A. Ma, and J. G. Bartlett. 2004. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch. Intern. Med. 164:637-644.
12. Kirby, B. D., K. M. Snyder, R. D. Meyer, and S. M. Finegold. 1980. Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature. Medicine (Baltimore) 59:188-205. (Pubitemid 10117855)
13. Miller, A. C. 1982. Hyponatraemia in Legionnaires' disease. Br. Med. J. (Clin. Res. Ed.) 284:558-559.
14. Nairz, M., I. Theurl, S. Ludwiczek, M. Theurl, S. M. Mair, G. Fritsche, and G. Weiss. 2007. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell. Microbiol. 9:2126-2140. (Pubitemid 47250286)
15. Niederman, M. S. 2008. Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin. Clin. Infect. Dis. 47(Suppl. 3):S127-S132.
16. Paradkar, P. N., I. De Domenico, N. Durchfort, I. Zohn, J. Kaplan, and D. M. Ward. 2008. Iron depletion limits intracellular bacterial growth in macrophages. Blood 112:866-874.
17. Smith, M. D., C. L. Sheppard, A. Hogan, T. G. Harrison, D. A. Dance, P. Derrington, R. C. George, and South West Pneumococcus Study Group. 2009. Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: a clinical comparison of pneumococcal PCR and urinary antigen detection. J. Clin. Microbiol. 47:1046-1049.
18. Weiss, G. 2005. Modification of iron regulation by the inflammatory response. Best Pract. Res. Clin. Haematol. 18:183-201.
19. Welte, T., and T. Koehnlein. 2009. Global and local epidemiology of community- acquired pneumonia: the experience of the CAPNETZ Network. Semin. Respir. Crit. Care Med. 30:127-130.
20. Yu, V. L., F. J. Kroboth, J. Shonnard, A. Brown, S. McDearman, and M. Magnussen. 1982. Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am. J. Med. 73:357-361.